Play all audios:
ABSTRACT BACKGROUND/OBJECTIVES Sarcopenia defined by the association of skeletal muscle mass depletion and a decreased physical performance is underdiagnosed in chronic obstructive pulmonary
disease (COPD) patients. The objective was to assess prevalence of sarcopenia and malnutrition in hospitalized COPD patients during an acute exacerbation, after 6 months follow-up and the
1-year survival. SUBJECTS/METHODS Hospitalized COPD patients were recruited for the assessment of body composition, handgrip strength, respiratory function, and maximal inspiratory and
expiratory pressures (MIP and MEP), during hospitalization and 6 months later. Sarcopenia was defined according to the criteria of the European Working Group on Sarcopenia in Older Adults,
malnutrition was defined according to French criteria 2007. Survival data were collected 12 months after hospitalization. RESULTS We analyzed data from 54 patients, aged 68 ± 9 years and BMI
26.9 ± 7.8 kg/m2, with an average FEV1 of 1.13 ± 0.49 l (45 ± 16% predicted value). Sarcopenia and malnutrition prevalence were, respectively, 48% and 52% during hospitalization, 30% and
30% after 6 months. MIP and MEP were lower in sarcopenic patients (_p_ = 0.01 and 0.009, respectively). In multivariate analysis, skeletal muscle mass index and MIP were positively
correlated at 6 months’ follow-up (_r_ = 0.40, _p_ = 0.04). The 1-year survival rate was lower in sarcopenic patients (65 vs 86%, _p_ = 0.03), particularly when malnutrition was associated
(_p_ = 0.02). CONCLUSIONS Sarcopenia in COPD patients is highly prevalent during and after recovery of an acute exacerbation, exposing to lower survival. A multimodal management is required
to treat sarcopenia and improve prognosis. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access
through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink *
Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional
subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS PREDICTION MODEL AND ASSESSMENT OF MALNUTRITION IN PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE
PULMONARY DISEASE Article Open access 18 March 2024 RESPIRATORY MUSCLE STRENGTH CAN IMPROVE THE PROGNOSTIC ASSESSMENT IN COPD Article Open access 29 May 2024 PREDICTION OF SARCOPENIA USING A
BATTERY OF CIRCULATING BIOMARKERS Article Open access 21 April 2021 REFERENCES * Soriano JB. An epidemiological overview of chronic obstructive pulmonary disease: what can real-life data
tell us about disease management? COPD. 2017;14(suppl 1):S3–7. Article Google Scholar * Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS
Med. 2006;3:e442. Article Google Scholar * GOLD. Global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease—GOLD; 2017.
http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/. * Molinari N, Chanez P, Roche N, Ahmed E, Vachier I, Bourdin A. Rising total costs and mortality rates
associated with admissions due to COPD exacerbations. Respir Res. 2016;17:149. Article Google Scholar * Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in
the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1791–7. Article CAS Google Scholar * Ehsan M, Khan R, Wakefield D, Qureshi A, Murray L,
Zuwallack R, et al. A longitudinal study evaluating the effect of exacerbations on physical activity in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc.
2013;10:559–64. Article Google Scholar * Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, et al. An Official American Thoracic Society/European Respiratory Society
Statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189:e15–62. Article Google Scholar * Schols AM, Ferreira IM, Franssen
FM, Gosker HR, Janssens W, Muscaritoli M, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J. 2014;44(Dec):1504–20. Article Google
Scholar * Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on
Sarcopenia in Older People. Age Ageing. 2010;39:412–23. Article Google Scholar * Kyle UG, Genton L, Hans D, Pichard C. Validation of a bioelectrical impedance analysis equation to predict
appendicular skeletal muscle mass (ASMM). Clin Nutr. 2003;22:537–43. Article CAS Google Scholar * Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, et al. Bioelectrical
impedance analysis-part I: review of principles and methods. Clin Nutr. 2004;23:1226–43. Article Google Scholar * Chien M-Y, Huang T-Y, Wu Y-T. Prevalence of sarcopenia estimated using a
bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc. 2008;56:1710–5. Article Google Scholar * Roberts HC, Denison HJ,
Martin HJ, Patel HP, Syddall H, Cooper C, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing.
2011;40:423–9. Article Google Scholar * Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on
mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851–60. Article Google Scholar * Thibault R, Goujon N, Le Gallic E, Clairand R, Sébille V, Vibert J, et al. Use
of 10-point analogue scales to estimate dietary intake: a prospective study in patients nutritionally at-risk. Clin Nutr. 2009;28(Apr):134–40. Article Google Scholar * Raynaud A,
Revel-Delhom C, Alexandre D, Alix E, Ancellin R, et al. Stratégies de prise en charge en cas de dénutrition protéino-énergetique de la personne âgée. Nutr Clin Métabolisme. 2007;21:120–33.
Article Google Scholar * ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care
Med. 2002;166:111–7. Article Google Scholar * Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise
capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–12. Article CAS Google Scholar * Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T,
et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am
J Respir Crit Care Med. 2006;173:79–83. Google Scholar * Smoliner C, Sieber CC, Wirth R. Prevalence of sarcopenia in geriatric hospitalized patients. J Am Med Dir Assoc. 2014;15:267–72.
Article Google Scholar * Rossi AP, Fantin F, Micciolo R, Bertocchi M, Bertassello P, Zanandrea V, et al. Identifying sarcopenia in acute care setting patients. J Am Med Dir Assoc.
2014;15:303.e7–12. Article Google Scholar * Jones SE, Maddocks M, Kon SSC, Canavan JL, Nolan CM, Clark AL, et al. Sarcopenia in COPD: prevalence, clinical correlates and response to
pulmonary rehabilitation. Thorax. 2015;70:213–8. Article Google Scholar * Patel HP, Syddall HE, Jameson K, Robinson S, Denison H, Roberts HC, et al. Prevalence of sarcopenia in
community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing.
2013;42:378–84. Article Google Scholar * Byun MK, Cho EN, Chang J, Ahn CM, Kim HJ. Sarcopenia correlates with systemic inflammation in COPD. Int J Chron Obstruct Pulmon Dis.
2017;12:669–75. Article CAS Google Scholar * Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with
chronic obstructive pulmonary disease: a placebo-controlled randomized trial. Am J Respir Crit Care Med. 1995;152:1268–74. Article CAS Google Scholar * Creutzberg EC, Wouters EFM, Mostert
R, Weling-Scheepers CAPM, Schols AMWJ. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition. 2003;19:120–7. Article
Google Scholar * Lim S, Kwon S-Y, Yoon JW, Kim SY, Choi SH, Park YJ, et al. Association between body composition and pulmonary function in elderly people: the Korean longitudinal study on
health and aging. Obesity. 2011;19:631–8. Article Google Scholar * Nishimura Y, Tsutsumi M, Nakata H, Tsunenari T, Maeda H, Yokoyama M. Relationship between respiratory muscle strength and
lean body mass in men with COPD. Chest. 1995;107:1232–6. Article CAS Google Scholar * Shin HI, Kim D-K, Seo KM, Kang SH, Lee SY, Son S. Relation between respiratory muscle strength and
skeletal muscle mass and hand grip strength in the healthy elderly. Ann Rehabil Med. 2017;41:686–92. Article Google Scholar * Ohara DG, Pegorari MS, Oliveira Dos Santos NL, de Fátima
Ribeiro Silva C, Monteiro RL, Matos AP, et al. Respiratory muscle strength as a discriminator of sarcopenia in community-dwelling elderly: a cross-sectional study. J Nutr Health Aging.
2018;22:952–8. Article CAS Google Scholar * Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the Six Minute Walk test in chronic
lung disease patients. Am J Respir Crit Care Med. 1997;155:1278–82. Article CAS Google Scholar * Hoogendoorn M, Hoogenveen RT, Rutten-van Mölken MP, Vestbo J, Feenstra TL. Case fatality
of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J. 2011;37:508–15. Article CAS Google Scholar * Celli BR, Locantore N, Yates J, Tal-Singer R, Miller
BE, Bakke P, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185:1065–72. Article CAS
Google Scholar * Schols AMWJ, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82:53–9. Article
CAS Google Scholar * de Blasio F, Di Gregorio A, de Blasio F, Bianco A, Bellofiore B, Scalfi L. Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary
disease according to international diagnostic criteria, and evaluation of raw BIA variables. Respir Med. 2018;134:1–5. Article Google Scholar * Boirie Y, Guillet C. Fast digestive proteins
and sarcopenia of aging. Curr Opin Clin Nutr Metab Care. 2018;21:37–41. Article CAS Google Scholar * Verlaan S, Maier AB, Bauer JM, Bautmans I, Brandt K, Donini LM, et al. Sufficient
levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults—the PROVIDE study. Clin Nutr. 2018;37:551–7. Article CAS Google Scholar *
Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89:465–71. Article CAS Google Scholar
Download references ACKNOWLEDGEMENTS The authors wish to acknowledge the Respiratory and Clinical Nutrition Departments of the University Hospital of Clermont-Ferrand for their assistance in
collecting data in this study. AUTHOR INFORMATION Author notes * L. Perrot Present address: Perrot Loïc, 42 Boulevard Jourdan, 75016, Paris, France AUTHORS AND AFFILIATIONS * CHU
Clermont-Ferrand, Service de Pneumologie, Clermont-Ferrand, France L. Perrot, A. Greil & D. Caillaud * CHU Clermont-Ferrand, Service de Nutrition Clinique, Clermont-Ferrand, France Y.
Boirie & N. Farigon * Université Clermont Auvergne, INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, Clermont-Ferrand, France Y. Boirie & F. Costes * CHU Clermont-Ferrand,
Délégation à la Recherche Clinique et l’Innovation, Clermont-Ferrand, France A. Mulliez * CHU Clermont-Ferrand, Service de Médecine du Sport et explorations fonctionnelles respiratoires,
Clermont-Ferrand, France F. Costes Authors * L. Perrot View author publications You can also search for this author inPubMed Google Scholar * A. Greil View author publications You can also
search for this author inPubMed Google Scholar * Y. Boirie View author publications You can also search for this author inPubMed Google Scholar * N. Farigon View author publications You can
also search for this author inPubMed Google Scholar * A. Mulliez View author publications You can also search for this author inPubMed Google Scholar * F. Costes View author publications You
can also search for this author inPubMed Google Scholar * D. Caillaud View author publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS LP, AG, YB, NF, and
FC conceived the study; LP carried out the study, managed, and analyzed data; LP and AM performed the statistical analysis; LP drafted the manuscript; AG, YB, FC, and DC reviewed the
manuscript. All authors read and approved the final manuscript. CORRESPONDING AUTHOR Correspondence to L. Perrot. ETHICS DECLARATIONS CONFLICT OF INTEREST The authors declare that they have
no conflict of interest. ADDITIONAL INFORMATION PUBLISHER’S NOTE Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. RIGHTS
AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Perrot, L., Greil, A., Boirie, Y. _et al._ Prevalence of sarcopenia and malnutrition during acute exacerbation
of COPD and after 6 months recovery. _Eur J Clin Nutr_ 74, 1556–1564 (2020). https://doi.org/10.1038/s41430-020-0623-6 Download citation * Received: 06 December 2019 * Revised: 15 March 2020
* Accepted: 23 March 2020 * Published: 15 April 2020 * Issue Date: November 2020 * DOI: https://doi.org/10.1038/s41430-020-0623-6 SHARE THIS ARTICLE Anyone you share the following link with
will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt
content-sharing initiative